SecSonar.com

GSK plc (GSK)

GSK plc at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.

GSK plc (GSK) is a Drug Manufacturers - General company based in GB with a market capitalization of $101.9B. Revenue grew 4.1% year-over-year and the company generated $7.8B in free cash flow. This page tracks GSK's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.

GB · 68.63K employees · IPO Mar 28, 1980

Valuation

Valuation & price

$51.49 · as of May 26, 2026 · -15.8% vs 52w high

—

P/E ratio

Latest-FY diluted EPS

—

P/B ratio

Market cap ÷ book equity

—

Dividend yield

Price — last 12 months

$61.18$48.69$36.20Jul 25Dec 25Jul 26Jul 7, 25$38.19Jul 9, 25$39.04Jul 11, 25$38.28Jul 15, 25$37.82Jul 17, 25$36.47Jul 21, 25$36.20Jul 23, 25$38.03Jul 25, 25$37.97Jul 29, 25$37.67Jul 31, 25$37.15Aug 4, 25$37.68Aug 6, 25$36.75Aug 11, 25$37.71Aug 13, 25$39.13Aug 15, 25$39.36Aug 19, 25$39.62Aug 21, 25$40.08Aug 25, 25$39.64Aug 27, 25$39.91Aug 29, 25$39.67Sep 3, 25$39.36Sep 5, 25$40.50Sep 9, 25$40.78Sep 11, 25$41.48Sep 16, 25$40.05Sep 18, 25$40.30Sep 22, 25$40.91Sep 24, 25$40.18Sep 26, 25$39.85Sep 30, 25$43.16Oct 2, 25$43.69Oct 6, 25$43.45Oct 8, 25$43.35Oct 10, 25$43.54Oct 14, 25$44.15Oct 16, 25$43.77Oct 21, 25$43.94Oct 23, 25$45.54Oct 27, 25$43.80Oct 29, 25$45.93Oct 31, 25$46.86Nov 4, 25$46.82Nov 6, 25$47.10Nov 10, 25$47.36Nov 12, 25$48.07Nov 14, 25$47.18Nov 18, 25$47.37Nov 20, 25$46.11Nov 25, 25$47.55Nov 28, 25$47.86Dec 2, 25$48.27Dec 4, 25$48.57Dec 8, 25$48.47Dec 10, 25$48.41Dec 12, 25$48.81Dec 16, 25$48.78Dec 18, 25$48.29Dec 22, 25$48.59Dec 24, 25$48.96Dec 29, 25$49.11Jan 2, 26$49.63Jan 6, 26$50.56Jan 8, 26$50.22Jan 12, 26$50.39Jan 14, 26$50.79Jan 16, 26$48.22Jan 21, 26$48.07Jan 23, 26$49.15Jan 27, 26$50.80Jan 29, 26$50.66Feb 2, 26$52.47Feb 4, 26$57.23Feb 9, 26$59.01Feb 11, 26$58.49Feb 13, 26$58.93Feb 18, 26$61.18Feb 20, 26$59.52Feb 24, 26$59.12Feb 26, 26$58.07Mar 2, 26$58.29Mar 4, 26$56.83Mar 6, 26$54.51Mar 10, 26$55.32Mar 12, 26$54.28Mar 17, 26$53.41Mar 19, 26$52.37Mar 23, 26$51.99Mar 25, 26$54.70Mar 27, 26$53.84Mar 31, 26$55.19Apr 2, 26$56.69Apr 7, 26$55.84Apr 9, 26$58.36Apr 13, 26$58.94Apr 15, 26$57.81Apr 17, 26$58.35Apr 22, 26$55.70Apr 24, 26$54.44Apr 28, 26$54.47Apr 30, 26$52.31May 4, 26$50.90May 6, 26$50.53May 8, 26$50.41May 12, 26$50.90May 14, 26$50.96May 18, 26$50.26May 20, 26$50.78May 22, 26$51.38May 28, 26$51.24Jun 1, 26$49.31Jun 3, 26$49.72Jun 5, 26$51.52Jun 9, 26$51.25Jun 11, 26$52.86Jun 15, 26$52.23Jun 17, 26$52.15Jun 22, 26$50.74Jun 24, 26$51.09Jun 26, 26$52.50Jul 2, 26$53.66
$36.2052-week range$61.18
Loading valuation history…

Fundamentals

Key fundamentals

$101.9B

Market cap

4.1%

Revenue growth (YoY)

72.4%

Gross margin

$7.8B

Free cash flow (USD)

$14.3B

Net debt

-50.3%

Share dilution

3/6

Graham criteria passed

Defensive-investor screen

Healthcare

Sector

Trajectory

Long-term trends

Revenue by year

2016 → 2025

FY 2016$27.9BFY 2017$30.2BFY 2018$30.8BFY 2019$33.8BFY 2020$24.4BFY 2021$24.7BFY 2022$29.3BFY 2023$30.3BFY 2024$31.4BFY 2025$32.7B
$27.9B$32.7B

Free cash flow by year

2016 → 2025

FY 2016$4.1BFY 2017$4.7BFY 2018$6.6BFY 2019$5.9BFY 2020$6.5BFY 2021$5.3BFY 2022$6.8BFY 2023$6.3BFY 2024$3.6BFY 2025$5.8B
$4.1B$5.8B

Gross margin by year

2021 → 2025

FY 202167.0%FY 202267.4%FY 202371.8%FY 202471.2%FY 202572.4%
67.0%72.4%

Value screen

Graham defensive-investor tests

Computing the scorecard — refreshing any stale inputs…

0

Insider buys · 90 days

0

Insider sells · 90 days

Earnings

Last report: 6-K filed May 22, 2026

Next expected: not yet scheduled

On the tape

Recent SEC & insider activity

  • 6-K filingTotal Voting RightsJul 1, 2026Filing
  • 6-K filingNotification of Major HoldingsJun 29, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 29, 2026Filing
  • 6-K filingNotification of Major HoldingsJun 26, 2026Filing
  • 6-K filingTender Offer AnnouncementJun 24, 2026Filing
  • 6-K filingDirector Shareholding NotificationJun 24, 2026Filing
  • 6-K filingDirector Shareholding NotificationJun 23, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 22, 2026Filing
  • 6-K filingFDA Approval AnnouncementJun 17, 2026Filing
  • 6-K filingShare Buyback AnnouncementJun 15, 2026Filing

Questions

Frequently asked questions

What is GSK plc's market cap?

GSK plc (GSK) has a market capitalization of $101.9B.

What is GSK's P/E ratio?

A meaningful P/E ratio is not available for GSK — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.

Are insiders buying GSK stock?

SEC Form 4 filings show no open-market insider buys at GSK plc in the last 90 days (0 sells).

Same arena

Related companies in Drug Manufacturers - General

SNY

Sanofi

$105.6B

PFE

Pfizer Inc.

$148.6B

GILD

Gilead Sciences, Inc.

$167.4B

ZTS

Zoetis Inc.

$32.6B

BIIB

Biogen Inc.

$29.2B

AMGN

Amgen Inc.

$180.9B

Timeline

Every filing, insider trade & earnings on a price-anchored timeline

Filing Analyzer

Search the actual 10-K / 10-Q text with AI research angles

News

Latest press coverage in one feed

Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.